FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...
FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...
(MENAFN- GlobeNewsWire - Nasdaq) FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the“Company”), a clinical-stage ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min “This is a story of a favorite ...
to raise $2 billion-equivalent in term loans to refinance existing unitranche debt. The financing will consist of loans in dollars and euros. Pricing on the seven-year, dollar-denominated term loan B ...
Visiting the DMV is as inevitable as death and taxes, with more than 8.5 million drivers taking to the streets across Illinois annually, according to the U.S. Department of Transportation. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback